GAS5

ncRNA information

ncRNA name

GAS5

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-21/PTEN

Cancer information

Cancer name

Liver Cancer

Cancer site

Liver

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Knockdown of GAS5 enhanced HCC cell proliferation in vitro and in vivo and increased HCC cell resistance to doxorubicin.

Tissue resource

hepatocellular carcinoma tissue specimens and matched adjacent normal tissues

human hepatocellular carcinoma cell lines HepG2

human hepatocellular carcinoma cell lines HepB3

human fetal hepatocyte cell lines LO2

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

the First Hospital of Quanzhou Affiliated to Fujian Medical University

American Type Culture Collection

Country

China

USA

Continent

Asia

North American